FundedIQ
Biotechnology

Othram: Funding, Investors & Team (Oct 2026)

There are hundreds of thousands of cold cases in the United States. Traditional forensic testing frameworks such as CODIS won’t help solve them. But new DNA testing technology can. Othram operates at the intersection of molecular biology, population genetics, and bioinformatics. Bridging 20th-century population genetics and 21st-century data science, we are the first and only forensic laboratory to vertically integrate a DNA test and human ID solution, that can identify victims, find missing persons, and reveal perpetrators of crimes. Othram achieves results even when other approaches fail.

www.othram.com LinkedIn The Woodlands, United States 51-100 employees
Biopharma Biotechnology Life Science B2C
Total raised
$6.6M
Rounds
1
Latest
Undisclosed round
Feb 2024

Othram has raised $6.6M across 1 funding round on record, the most recent an undisclosed round of $6.6M announced in Feb 2024.

That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Othram Company Profile and Key Stats

Total funding raised
$6.6M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$6.6M in Feb 2024
Employees
51-100
reported band
Headquarters
The Woodlands, United States

Latest funding round on record: Feb 2024.

Othram Funding Rounds

Date
Round
Amount
Undisclosed round
$6.6M

Othram Founders and Leadership Team

Name
Role
Contact
David Mittelman
Founder
Locked

Contact details for the Othram team: 1 of 1 has an email address on file.

Start 14-day free trial →

Othram Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M

Othram's latest round of $6.6M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Othram in Biotechnology and The Woodlands

Companies Similar to Othram

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Othram Funding FAQs

What does Othram do?

There are hundreds of thousands of cold cases in the United States. Traditional forensic testing frameworks such as CODIS won’t help solve them. But new DNA testing technology can. Othram operates at the intersection of molecular biology, population genetics, and bioinformatics. Bridging 20th-century population genetics and 21st-century data science, we are the first and only forensic laboratory to vertically integrate a DNA test and human ID solution, that can identify victims, find missing persons, and reveal perpetrators of crimes. Othram achieves results even when other approaches fail.

How much funding has Othram raised?

Othram has raised $6.6M across 1 round on record. The most recent is an undisclosed round of $6.6M announced in Feb 2024.

When did Othram last raise funding?

Othram's most recent funding round on record is an undisclosed round of $6.6M, announced in Feb 2024.

Who founded Othram?

FundedIQ lists David Mittelman (Founder) at Othram.

Where is Othram headquartered?

Othram is based in The Woodlands, Texas, United States.

How many employees does Othram have?

Othram is in the 51-100 employee band.

How does Othram's funding compare to other Biotechnology startups?

Othram's latest round of $6.6M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Othram Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Othram is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.